Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients

Clin J Am Soc Nephrol. 2021 Nov;16(11):1720-1722. doi: 10.2215/CJN.06450521. Epub 2021 Jul 26.
No abstract available

Keywords: COVID-19; SARS-CoV-2; antibody; dialysis; vaccination.

Publication types

  • Comparative Study
  • Letter
  • Observational Study

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Ad26COVS1
  • Adenoviridae / genetics*
  • Antibodies, Viral / blood
  • BNT162 Vaccine
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / adverse effects
  • Genetic Vectors*
  • Host-Pathogen Interactions
  • Humans
  • Immunity, Humoral / drug effects*
  • Immunogenicity, Vaccine*
  • Immunoglobulin G / blood
  • Kidney Diseases / diagnosis
  • Kidney Diseases / immunology
  • Kidney Diseases / therapy*
  • Renal Dialysis* / adverse effects
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity
  • Time Factors
  • Treatment Outcome
  • Vaccination

Substances

  • Ad26COVS1
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Immunoglobulin G
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine